A proposal of the signaling pathway of MELK that highlights stathmin activation via FOXM1 and p53 is presented in Fig. 6, where a disturbance on the pathway involving MELK and stathmin may lead to alterations of tumor cell cycle progression, proliferation, and migration. The gene discussed is MELK; the disease is neoplasm.